Choom Holdings Inc (CHOOF)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Choom Holdings Revenue (Quarterly): 3.344M for Dec. 31, 2021
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 3.344M |
| September 30, 2021 | 3.843M |
| June 30, 2021 | 3.974M |
| March 31, 2021 | 4.027M |
| December 31, 2020 | 4.663M |
| September 30, 2020 | 4.491M |
| June 30, 2020 | 2.849M |
| March 31, 2020 | 1.535M |
| December 31, 2019 | 1.022M |
| September 30, 2019 | 0.1427M |
| June 30, 2019 | 0.0902M |
| March 31, 2019 | 0.0808M |
| December 31, 2018 | 0.0304M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 |
| Date | Value |
|---|---|
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | -0.0062M |
| March 31, 2011 | 0.0029M |
| December 31, 2010 | 0.0031M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.1427M
Minimum
Sep 2019
4.663M
Maximum
Dec 2020
2.989M
Average
3.594M
Median
Revenue (Quarterly) Benchmarks
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -- |
| Canntab Therapeutics Ltd | -0.0164M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 57.19M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.68M |
| Total Expenses (Quarterly) | 4.252M |
| EPS Diluted (Quarterly) | -0.0079 |